Kim Brazzell
2022
In 2022, Kim Brazzell earned a total compensation of $993.7K as Head of Research and Development and Chief Medical Officer at Kala Pharmaceuticals, a 25% decrease compared to previous year.
Compensation breakdown
| Bonus | $225,000 |
|---|---|
| Option Awards | $242,777 |
| Salary | $500,000 |
| Other | $25,912 |
| Total | $993,689 |
Brazzell received $500K in salary, accounting for 50% of the total pay in 2022.
Brazzell also received $225K in bonus, $242.8K in option awards and $25.9K in other compensation.
Rankings
In 2022, Kim Brazzell's compensation ranked 2,989th out of 5,505 executives tracked by ExecPay. In other words, Brazzell earned more than 45.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,989 out of 5,505 | 46th |
Division Manufacturing | 1,673 out of 2,984 | 44th |
Major group Chemicals And Allied Products | 780 out of 1,339 | 42nd |
Industry group Drugs | 726 out of 1,242 | 42nd |
Industry Pharmaceutical Preparations | 524 out of 896 | 42nd |
Source: SEC filing on March 13, 2023.
Brazzell's colleagues
We found two more compensation records of executives who worked with Kim Brazzell at Kala Pharmaceuticals in 2022.